PetMeds grants CEO Willard 250,000 restricted shares and 250,000 performance share units
PETS•PetMed Express granted newly hired CEO Jeff Willard 250,000 restricted shares and 250,000 performance share units under its inducement plan. The company also granted new CTO Andrew Parry 100,000 restricted shares.
1. Executive equity awards
Willard’s restricted shares vest in three equal annual installments, beginning on the first anniversary of the Sept. 28, 2026, grant date. His performance share units convert to common shares based on total shareholder return versus the S&P 600 Specialty Retail Index through Sept. 27, 2029.
2. CTO award
Parry received 100,000 restricted shares on Oct. 1, 2026, vesting in three equal annual installments. The awards were made under the amended and restated 2024 Inducement Incentive Plan, following a September 2026 amendment.
